Systemic treatment with Mycobacterium bovis bacillus calmette-guerin (BCG) potentiates kinin B1 receptor agonist-induced nociception and oedema formation in the formalin test in mice

Neuropeptides

Volumn 32, Issue 5, 1998, Pages 393-403

  De Campos, R O P ^a   Henriques, M G M O ^b   Calixto, J B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b Department of Applied Pharmacology   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR AGONIST; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR AGONIST; BRADYKININ DERIVATIVE; BRADYKININ[1-8]; BRADYKININ[8 LEUCINE 9 DEARGININE]; BRADYKININ[8 TYROSINE]; DEXAMETHASONE; FORMALDEHYDE; ICATIBANT; INDOMETACIN; KALLIDIN[1-9]; PHENIDONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; MYCOBACTERIUM BOVIS; NEUROIMMUNOLOGY; NEUROMODULATION; NOCICEPTION; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA; MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG;

EID: 0031736665     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(98)90062-2     Document Type: Article

References (42)

1. Regoli D, Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980; 32: 1-46.
2. Proud D, Kaplan A P. Kinin formation: mechanisms and role in inflammatory disorders. Annu Rev Immunol 1988; 6: 49-83.
3. Steranka L R, Burch R M. Bradykinin antagonists in pain and inflammation. In: Burch R M (ed) Bradykinin Antagonists: Basical and Clinical Research. Marcel Dekker Inc, New York 1991, p. 191-211.
4. Bhoola K D, Figueroa C D, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992; 44: 1-80.
5. Farmer S G, Burch R M. Biochemical and molecular pharmacology of kinin receptors. Annu Rev Pharmacol Toxicol 1995; 32: 511-532.
6. Hall J M. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol ther and ther 1992; 56: 131-190.
7. Dray A, Perkins M N. Kinins and pain. In: Farmer S G (ed) The Kinin System. Academic Press Inc, San Diego 1997, p. 157-172.
8. 1 receptors: a review. Immunopharmacology 1995; 30: 1-26.
9. Collier H O, Lee I R. Algesic actions of bradykinin. Br J Pharmacol 1963; 21: 151-158.
10. Franz M, Mense S. Muscle receptors with group IV afferent fibres responding to application of bradykinin. Brain Res 1975; 92: 369-383.
11. Szolcsányi J. Selective responsiveness of polymodal nociceptors of rabbit ear to capsaicin, bradykinin and ultraviolet irradiation. J Physiol 1987; 388: 9-23.
12. Dray A, Patel I A, Perkins M N, Rueff A. Bradykinin-induced activation of nociceptors: receptors and mechanistic studies in the neonatal rat spinal cord-tail preparation in vitro. Br J Pharmacol 1992; 107: 1129-1134.
13. 2 receptor mechanisms and cytokine induced hyperalgesia in the rat. Can J Physiol Pharmacol 1995; 73: 832-836.
14. 1 bradykinin receptors and sensory neurones. Br J Pharmacol 1996; 118: 1469-1476.
15. Dray A. Kinins and their receptors in hyperalgesia. Can J Physiol Pharmacol 1997; 75: 704-712.
16. Geppetti P. Sensory neuropeptide release by bradykinin: Mechanisms and pathophysiological implications. Regul Pept 1993; 47: 1-23.
17. 2 kinin receptors in formalin-induced nociceptive response in the mouse. Br J Pharmacol 1993; 110: 193-198.
18. 1 kinin receptors mediating paw oedema and formalin-induced nociception. Modulation by glucocorticoids. Can J Physiol Pharmacol 1995; 73: 812-819.
19. 2 bradykinin receptor antagonist NPC 18688 in mice. Br J Pharmacol 1996; 117: 552-558.
20. 2 receptor antagonist. Eur J Pharmacol 1996; 316: 277-286.
21. Haley J E, Dickenson A H, Schachter M. Electrophysiological evidence for a role of bradykinin in chemical nociception in the rat. Neurosci Lett 1989; 97: 198-202.
22. Shibata M, Ohkubo T, Takahashi H, Inoki R. Interaction of bradykinin with substance P on vascular permeability and pain response. Jpn J Pharmacol 1986; 41: 427-429.
23. Shibata M, Ohkubo T, Takahashi H, Inoki R. Modified formalin test: characteristic biphasic pain response. Pain 1989; 38: 347-352.
24. Chapman V, Dickenson A H. The spinal and peripheral roles of bradykinin and prostaglandins in nociceptive processing in the rat. Eur J Pharmacol 1992; 219: 427-433.
25. 2 receptor on nociception in rats and mice. Pain 1997; 71: 89-97.
26. 2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG). Br J Pharmacol 1997; 120: 502-508.
27. 2 receptors in bradykimn-induced rat paw oedema. Br J Pharmacol 1995; 114: 1005-1013.
28. 9 -Bradykinin-induced rat paw oedema by systemic treatment with bacterial endotoxin. Br J Pharmacol 1996; 117: 793-798.
29. Bohle A, Nowc C, Ulmer A J et al. Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus calmette-Guérin immunotherapy. J Urol 1990; 144: 59-64.
30. Dereijke T M, Vos P C, Deboer E C et al. Cytokine production by human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Guérin (BCG). Urol Res 1993; 21: 349-352.
31. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109-110.
32. Hunskaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 1987; 30: 103-114.
33. Mass J, Rae G A, Huidobro-Toro J P, Calixto J B. Characterization of kinin receptors modulating neurogenic contractions of the mouse isolated vas deferens. Br J Pharmacol 1995; 114: 1471-1477.
34. 1 receptor gene. Biochem Biophys 1996; 220: 219-225.
35. 9-bradykinin in mouse pleurisy. Br J Pharmacol 1998; 123: 281-291.
36. 9-bradykinin. Br J Pharmacol 1988; 93: 969-977.
37. 9-bradykinin: possible role of interleukin-1. Br J Pharmacol 1991; 103: 314-315.
38. 1 receptors in the polymorphonuclear leucocyte accumulation induced by IL-1β in vivo in the mouse. J Immunol 1996; 73: 269-274.
39. Donaldson L F, Hanley M R, Villablanca A C. Inducible receptors. Trends in Pharmacol Sci 1997; 18: 171-181.
40. 1 receptors in vivo in a model of ultraviolet irradiation-induced thermal hyperalgesia in the rat. Br J Pharmacol 1993; 110: 1441-1444.
41. 8]-bradykinin and Hoe 140, in two models of persistent hyperalgesia in the rat. Pain 1993; 53: 191-197.
42. 9-bradykinin in vitro and in vivo. Br J Pharmacol 1987; 92: 257-264.